Report #2868836

Received Oct 27, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: —
Recovered: Recovered
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	UNK	—

Symptoms (1)

Influenza

Symptom narrative

Small flu; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of influenza in a 56-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on an unknown date). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced influenza (Verbatim: Small flu). The outcome of the influenza was resolved. The reporter considered the influenza to be related to Shingrix. The company considered the influenza to be related to Shingrix. Additional Information: GSK receipt date: 14-OCT-2025 Reporter stated that Shingrix was one vaccine they were fine with. No mRNA, no retarded adjuvants or additives. Totally safe and effective except for the usual extremely rare Gullion Barre risk. Reporter got it at 56. No problems but the second dose does gives a small flu like day or two. This case was 1 of 3 cases reported by same reporter.